Navigation Links
How to increase the chances of remaining virus free Pakistani patients with HCV?
Date:5/20/2008

Hepatitis C is a health care problem all over the world, with 130 million patients infected the world over. The treatment is expensive and has variable results according to the genotype of the infecting virus. The first land mark in treatment is the virus clearance at the end of the treatment called End Treatment Response (ETR), but many of the patients achieving the ETR have a relapse within the next six months. Thus, the goal of treatment is to have persistent virus clearance until six months after completing the treatment. This is called Sustained Virological Response (SVR). It is difficult to predict the SVR in patients receiving ongoing therapy.

A team of doctors, led by Dr. Bader Faiyaz Zuberi at Dow University of Health Sciences, Pakistan, conducted a study and their article will be published on April 14, 2008 in the World Journal of Gastroenterology. In this article they show that in patients with genotype-3 HCV who achieve virus clearance in the first four weeks of therapy, called Rapid Virological Response (RVR) with standard interferon, there is a high probability of achieving the SVR. They also show that patients with initial high levels of ALT were also more likely to attain RVR.

The study will help in selection and prediction of response in patients with Hepatitis C being treated with standard interferon. Pegylated interferon is very expensive and is not within the reach of most patients in developing countries.


'/>"/>

Contact: Jing Zhu
wjg@wjgnet.com
86-105-908-0039
World Journal of Gastroenterology
Source:Eurekalert

Page: 1

Related medicine news :

1. Men at increased risk of death from pneumonia compared to women
2. Mastectomies on the Increase
3. Tempo Participacoes Announces Increase of 34% in EBITDA and of 25% in Net Revenue for the 1Q08
4. Hidden heart condition increases the risk of death in patients waiting for kidney transplants
5. AUA 2008: Global warming may lead to increase in kidney stones disease
6. Congressional Passage of Pool and Spa Safety Legislation Increases Need for Higher Education
7. Study shows that prostate cancer increases the risk of bone fracture
8. The Female Health Company Reports 267% Increase in Second Quarter Earnings
9. MSA Increases Second Quarter Dividend
10. Updated Microsoft Health Common User Interface Furthers Clinical Effectiveness, Increases Patient Safety
11. Metoprolol around the time of surgery increases the risk of death and stroke: POISE trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/20/2017)... ... ... Team Type 1 Foundation, a nonprofit organization pursuing a global mission of ... up with a Microsoft Corp. employee-led hackathon team for the 2017 Microsoft One Week ... Type 1’s mission overlaps seamlessly with Microsoft’s mission to empower every person and every ...
(Date:7/20/2017)... ... July 20, 2017 , ... Using ... Aug. 9, 2017 — 1:30 p.m. – 3:00 p.m. ET, http://www.fdanews.com/mdqualitydata          ... boosting quality. , It’s known as the “CY2016 Annual FDA Medical Device Quality ...
(Date:7/20/2017)... ... 2017 , ... The Business Architecture Guild® is pleases to ... )v 6.0 is now available for member download. This release is dedicated to ... Non-members may download the Part 1 Introduction for free at http://www.businessarchitectureguild.org. ...
(Date:7/20/2017)... ... July 19, 2017 , ... A local summer ... increased funds raised to support fine arts programs in Chester County’s Elementary Schools. ... Freed-Hardeman University’s Loyd Auditorium. , More than 850 people attended the two ...
(Date:7/20/2017)... ... July 19, 2017 , ... ... million Health Resources and Services Administration (HRSA) grant to train predoctoral dental students ... care needs in rural and underserved areas. , The Predoctoral Pediatric Training Project ...
Breaking Medicine News(10 mins):
(Date:7/10/2017)... 2017  BDI Group subsidiary Pathway Purchasing Network, ... organization serving specialty pharmacies, home infusion companies and ... significant, value-added member programs designed to help organizations ... and improve access and affordability for patients who ... Pathway has worked ...
(Date:7/5/2017)... Oramed Pharmaceuticals Inc. (NASDAQ: ... clinical-stage pharmaceutical company focused on the development of oral drug ... the Israel Securities Authority to dual-list its common stock on ... commence trading on the TASE on July 12, 2017 under ... the Company, it is expected that Oramed will be included ...
(Date:6/30/2017)... -- AVACEN Medical (AVACEN) announced the publication of new research in the ... its AVACEN Treatment Method to significantly reduce the widespread ... ... ... approximately 200 to 400 million people worldwide according to The National ...
Breaking Medicine Technology: